Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Clinical trials sponsored by Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., explained in plain language.

Now part of Chongqing Zhifei Biological Products Co., Ltd. 300122 SZSE

A Chinese vaccine manufacturer, subsidiary of Chongqing Zhifei Biological Products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

Can a TB vaccine stop bladder cancer from coming back?

Prevention Ongoing

This Phase 3 trial tests whether a therapeutic BCG vaccine, given directly into the bladder, can prevent non-muscle-invasive bladder cancer from returning after surgery. About 439 adults with intermediate- or high-risk cancer are participating. The study compares BCG to an active…

Phase 3 • Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. • Aim: Prevention

Last updated Jun 27, 2026 12:25 UTC

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Can a TB vaccine stop bladder cancer from coming back?